TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17493669

Group type: EXPERIMENTAL
Intervention: NACT+RHPPL (vincristine-cisplatin chemotherapy every 10 days for 3 cycles before RHPPL)
Number of subjects: 288

Group type: COMPARATOR
Intervention: RHPPL only
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: NACT+RHPPL
Number of subjects: 288
Study: 15339409

Group type: EXPERIMENTAL
Intervention: Fuzheng Yiliu Granule plus radiotherapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 63
Study: 11840766

Group type: EXPERIMENTAL
Intervention: Attenuated live hepatitis A vaccine (H2 strain) - 10(6.5) TCID50/ml
Number of subjects: 37000

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 37000
Study: 10052106

Group type: EXPERIMENTAL
Intervention: Women with uterine fibromatosis
Number of subjects: 31

Group type: COMPARATOR
Intervention: Women without pathology (control group)
Number of subjects: 31
Study: 7474005

Group type: EXPERIMENTAL
Intervention: Primary repair or resection and anastomosis
Number of subjects: 71

Group type: COMPARATOR
Intervention: Diversion
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Primary repair with resection of colon
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Primary repair or resection with anastomosis
Number of subjects: 71
Study: 2147844

Group type: EXPERIMENTAL
Intervention: 0.1% thymoxamine
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 0.1% thymoxamine (light irides)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 0.1% thymoxamine (dark irides)
Number of subjects: 74
Study: 7356821

Group type: EXPERIMENTAL
Intervention: Systematic filmed programmed instruction
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (slides, bibliotherapy, nonprogrammed activity)
Number of subjects: 14
Study: 30910634

Group type: EXPERIMENTAL
Intervention: Coated tablets
Number of subjects: 84

Group type: COMPARATOR
Intervention: Uncoated tablet
Number of subjects: 84
Study: 28362327

Group type: EXPERIMENTAL
Intervention: Forest bathing
Number of subjects: 2

Group type: COMPARATOR
Intervention: Urban control area
Number of subjects: 2
Study: 26293505

Group type: EXPERIMENTAL
Intervention: Moderate exercise (EX) for 6 months
Number of subjects: 101

Group type: COMPARATOR
Intervention: Health education control (CON)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Moderate exercise (EX)
Number of subjects: 101
Study: 24070104

Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy for Primary Care (PST‐PC), delivered in 8 weekly telephone sessions of 30-45 minutes duration and 4 monthly maintenance sessions.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (referral to general practitioner for assessment and treatment)
Number of subjects: 0
Study: 20978640

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive (SEA) applied on dentin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive (SEA) applied on water contaminated dentin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive (SEA) applied on saliva contaminated dentin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Polyalkenoic acid conditioning
Number of subjects: 70

Group type: COMPARATOR
Intervention: No surface treatment
Number of subjects: 70
Study: 18991972

Group type: EXPERIMENTAL
Intervention: STM touch with ISIO4 blended oil for 10 days
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: STM touch with sweet almond oil for 10 days
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: All STM groups (almond oil, ISIO4 oil)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study: 16777920

Group type: EXPERIMENTAL
Intervention: Zinc carnosine (ZnC) 37.5 mg twice daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 15623266

Group type: EXPERIMENTAL
Intervention: Intervention group (physicians receiving education on PIM prescribing)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Control group (usual care physicians)
Number of subjects: 355
Study: 11794219

Group type: EXPERIMENTAL
Intervention: Inactivated trivalent split‐virus influenza vaccine
Number of subjects: 2032

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2032
Study: 9424902

Group type: EXPERIMENTAL
Intervention: Gastroenterostomy (ZZJ)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Billroth II method (BII)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy with pyloroplasty (VP)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Highly selective vagotomy (WWW)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Rydygier method (BI-R)
Number of subjects: 170
Study: 7819733

Group type: EXPERIMENTAL
Intervention: Presoaked porcine collagen shields with 0.1% betamethasone disodium phosphate and 0.5% netilmycin (group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Subconjunctival injection of 1 mg betamethasone disodium phosphate and 250 mg piperacillin (group 2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (1 and 2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Collagen shields
Number of subjects: 50
Study: 3337463

Group type: EXPERIMENTAL
Intervention: Albuterol (4 mg three times daily for 3 days)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31873050

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 1149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1149
Study: 29701119

Group type: EXPERIMENTAL
Intervention: Blood flow restriction training (n=12)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (n=14)
Number of subjects: 26
Study: 28857042

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Cognitive-Behavioural Therapy (CBT)
Number of subjects: 440
Study: 26307337

Group type: EXPERIMENTAL
Intervention: Specific laryngeal manipulation (SLM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Postural manual therapy (PMT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (neither SLM nor PMT)
Number of subjects: 12
Study: 23879752

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin (600 mg loading dose followed by 75 mg/day, with open-label aspirin 50-325 mg/day, recommended 162 mg for 5 days then 81 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin alone (50-325 mg/day, with a recommended dose of 162 mg for 5 days then 81 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 0
Study: 20953211

Group type: EXPERIMENTAL
Intervention: rhTNFR-Fc 12.5, 25, 37.5, or 50 mg SC injection (healthy volunteers)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: rhTNFR-Fc 25 mg BIW or 50 mg QW (patients with AS)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: rhTNFR-Fc (multiple dosages)
Number of subjects: 52
Study: 18853110

Group type: EXPERIMENTAL
Intervention: Kushenin 0.6 g once a day
Number of subjects: 55
Study: 16649350

Group type: EXPERIMENTAL
Intervention: Folic acid (1 mg) for 3 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 14662554

Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/d)
Number of subjects: 453

Group type: COMPARATOR
Intervention: Haloperidol (3-15 mg/d)
Number of subjects: 453
Study: 11253478

Group type: EXPERIMENTAL
Intervention: Cognitive tasks (linguistic and visuospatial)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 16
Study: 8769301

Group type: EXPERIMENTAL
Intervention: 5 MU IFN three times a week for six months
Number of subjects: 45

Group type: COMPARATOR
Intervention: 5 MU IFN daily until HCV-RNA was undetectable in plasma X 3 over 3 consecutive monthly determinations followed by demonstrated HCV-RNA negativity in liver biopsy tissue
Number of subjects: 45
Study: 1570963

Group type: EXPERIMENTAL
Intervention: Normal saline injection
Number of subjects: 260

Group type: COMPARATOR
Intervention: Normal saline containing 10 U per 1 mL heparin
Number of subjects: 260
Study: 6099649

Group type: EXPERIMENTAL
Intervention: Towne live, attenuated cytomegalovirus (CMV) vaccine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Seropositive kidney transplant
Number of subjects: 53
Study: 30478937

Group type: EXPERIMENTAL
Intervention: MD-Logic closed-loop system
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sensor-augmented pump (SAP) therapy
Number of subjects: 48
Study: 30337083

Group type: EXPERIMENTAL
Intervention: Physiologically relevant respiratory model predicting peak inspiratory pressure after changes to PEEP.
Number of subjects: 4
Study: 26851768

Group type: EXPERIMENTAL
Intervention: Active 2 mA tPCS stimulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 25200403

Group type: EXPERIMENTAL
Intervention: pantoprazole 40 mg daily for 8 weeks
Number of subjects: 209
Study: 22085206

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation participation
Number of subjects: 104

Group type: COMPARATOR
Intervention: Traditional clinical experience (Control)
Number of subjects: 104
Study: 19268343

Group type: COMPARATOR
Intervention: Sending right pelvic nodes in a single container
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sending left pelvic nodes in a single container
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Sending pelvic nodes in four containers
Number of subjects: 104
Study: 16815741

Group type: EXPERIMENTAL
Intervention: POEM system (Web-based patient-oriented diabetic education management)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control group (standard education)
Number of subjects: 274
Study: 16411341

Group type: EXPERIMENTAL
Intervention: Thai regimen (zidovudine 300 mg po bid from 36 weeks until labour, zidovudine 300 mg po q3h during labour; neonates received placebo)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Ultra-Short regimen (placebo from 36 weeks to labour, zidovudine 300 mg po q3h in labour; neonates received zidovudine 2 mg/kg po qid for the first three days)
Number of subjects: 222
Study: 11673297

Group type: EXPERIMENTAL
Intervention: Phacovitrectomy surgery without prone posture
Number of subjects: 20

Group type: COMPARATOR
Intervention: Phacovitrectomy with gas tamponade and face down posturing (historical control)
Number of subjects: 20
Study: 9640061

Group type: EXPERIMENTAL
Intervention: Treatment for tick-borne encephalitis (exact treatment details not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (exact details not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bacterial meningitis group (exact details not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detection of cytokines in CSF
Number of subjects: 0
Study: 7734459

Group type: EXPERIMENTAL
Intervention: Contingency contracting (CC)
Number of subjects: 360

Group type: COMPARATOR
Intervention: No contingencies (NC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Medication only/CC
Number of subjects: 360

Group type: COMPARATOR
Intervention: Medication only/NC
Number of subjects: 360
Study: 2466359

Group type: EXPERIMENTAL
Intervention: Oxendolone 200 mg weekly
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31659986

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Stent treatment (bare metal stents (BMS) or drug-eluting stents (DES))
Number of subjects: 210

Group type: COMPARATOR
Intervention: Stent treatment (BMS or DES)
Number of subjects: 210
Study: 29158012

Group type: EXPERIMENTAL
Intervention: OLZ+SAM (10mg olanzapine + 5mg samidorphan)
Number of subjects: 106

Group type: COMPARATOR
Intervention: OLZ alone (10mg olanzapine)
Number of subjects: 106

Group type: COMPARATOR
Intervention: SAM alone (5mg samidorphan)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 26968718

Group type: EXPERIMENTAL
Intervention: Scleral Buckling (SB)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Vitrectomy without band
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Vitrectomy with encircling band (EB)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Triamcinolone Acetonide (TA) assisted vitrectomy
Number of subjects: 211
Study: 24631792

Group type: EXPERIMENTAL
Intervention: Group A (55-65 minutes of exercise at 4-5 times a week)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Group B (45-55 minutes of exercise at 2-3 times a week)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no physical activity)
Number of subjects: 50
Study: 22623389

Group type: EXPERIMENTAL
Intervention: Oily fish intake (two 150-g salmon portions/wk)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (habitual diet low in oily fish)
Number of subjects: 123
Study: 21092748

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP)
Number of subjects: 1220

Group type: COMPARATOR
Intervention: Risperidone long-acting injectable (RIS‐LAI)
Number of subjects: 1220
Study: 18160258

Group type: EXPERIMENTAL
Intervention: Chemically acidified formula with probiotics (Bifidobacterium lactis)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Chemically acidified formula without probiotics
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Biologically acidified formula
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard whey formula
Number of subjects: 132
Study: 16730011

Group type: EXPERIMENTAL
Intervention: Saline wound irrigation
Number of subjects: 206

Group type: COMPARATOR
Intervention: No saline wound irrigation (Control)
Number of subjects: 206
Study: 12881375

Group type: EXPERIMENTAL
Intervention: Regular mammography screening
Number of subjects: 0
Study: 10918536

Group type: EXPERIMENTAL
Intervention: Contingent access to sedentary activities based on 750 pedometer counts
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Contingent access to sedentary activities based on 1500 pedometer counts
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (noncontingent access to sedentary behaviors)
Number of subjects: 34
Study: 8875083

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study: 1561466

Group type: EXPERIMENTAL
Intervention: 50 mg of sustained-release isosorbide 5-mononitrate (5-IMN)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Daily administration of 50 mg of sustained-release isosorbide 5-mononitrate (5-IMN) for 3 weeks
Number of subjects: 10
Study: 3893693

Group type: EXPERIMENTAL
Intervention: Epirubicin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Epirubicin and Doxorubicin
Number of subjects: 16
Study: 31162103

Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy with short-term hormone therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salvage radiotherapy without short-term hormone therapy
Number of subjects: 0
Study: 29665130

Group type: EXPERIMENTAL
Intervention: Cocktail of digoxin (0.25 mg), furosemide (1 mg), metformin (10 mg), and rosuvastatin (10 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Single drug treatments (digoxin, furosemide, metformin, rosuvastatin)
Number of subjects: 30
Study: 27178366

Group type: EXPERIMENTAL
Intervention: Prednisolone (250 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 25100550

Group type: EXPERIMENTAL
Intervention: Telehealth-supported service
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard service
Number of subjects: 63
Study: 22582680

Group type: EXPERIMENTAL
Intervention: Lavender aroma exposure (5 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Absence of lavender (control)
Number of subjects: 15
Study: 20309531

Group type: EXPERIMENTAL
Intervention: Nicotine (21 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 18621987

Group type: EXPERIMENTAL
Intervention: Intraluminal 70% ethanol/water
Number of subjects: 64

Group type: COMPARATOR
Intervention: Heparinized saline
Number of subjects: 64
Study: 16488641

Group type: EXPERIMENTAL
Intervention: Exercise program combined with cognitive tasks (dual-task group, N=37)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Exercise program alone (single-task group, N=31)
Number of subjects: 68
Study: 15022655

Group type: EXPERIMENTAL
Intervention: Honey mixture (honey, beeswax, and olive oil)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Mixture C (honey mixture with corticosteroids in a 3:1 ratio)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Honey mixture
Number of subjects: 39
Study: 11094673

Group type: EXPERIMENTAL
Intervention: Leukoplast tape
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sleek tape
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taping method (tape parallel to cannula axis and taping hub-giving set connection)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sterile adhesive dressings and tapes
Number of subjects: 0
Study: 8756050

Group type: EXPERIMENTAL
Intervention: Oral administration of 500 mg quinine base
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of 500 mg quinine base
Number of subjects: 18
Study: 1562344

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 66
Study: 3902482

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31033161

Group type: EXPERIMENTAL
Intervention: SC 1,3‐butanediol extract
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (no extract)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Positive control (kojic acid)
Number of subjects: 30
Study: 27848021

Group type: EXPERIMENTAL
Intervention: Active (estim + swallow exercise)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sham (sham estim + swallowing exercise)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: All patients pooled together
Number of subjects: 170
Study: 26049126

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT), 4 sessions
Number of subjects: 31

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 31
Study: 24075759

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 units oral)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 21709591

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 1237

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 1237

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1237
Study: 19071997

Group type: EXPERIMENTAL
Intervention: Causal Inference in Randomized Experiments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross-model translation (CMT) approach
Number of subjects: 0
Study: 16501039

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 30
Study: 15031570

Group type: EXPERIMENTAL
Intervention: BiPAP plus standard therapy (group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard therapy alone (group 2)
Number of subjects: 30
Study: 11226986

Group type: EXPERIMENTAL
Intervention: Pulsed Doppler sonography (PDS) of the hilar renal artery
Number of subjects: 80
Study: 9315764

Group type: EXPERIMENTAL
Intervention: Ambulatory Blood Pressure (ABP) measurement
Number of subjects: 419

Group type: COMPARATOR
Intervention: Conventional Blood Pressure (CBP) measurement
Number of subjects: 419
Study: 7693793

Group type: EXPERIMENTAL
Intervention: Single transfusion of the partner's lymphocytes in the third week of pregnancy
Number of subjects: 22

Group type: COMPARATOR
Intervention: One to three transfusions of the partner's lymphocytes before the pregnancy started
Number of subjects: 22

Group type: COMPARATOR
Intervention: Pre-conceptual transfusions
Number of subjects: 22
Study: 3710290

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (PK 10169)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 8
Study: 28318309

Group type: EXPERIMENTAL
Intervention: Fostering Healthy Futures program (9‐month mentoring and skills group preventive intervention)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Fostering Healthy Futures program
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 156
Study: 29456149

Group type: EXPERIMENTAL
Intervention: Universal Medication Schedule (UMS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 76
Study: 27177605

Group type: EXPERIMENTAL
Intervention: Sofosbuvir and velpatasvir for 12 weeks
Number of subjects: 1
Study: 24077325

Group type: EXPERIMENTAL
Intervention: Cytochrome c levels at least the mean peak level
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cytochrome c levels below the mean peak level
Number of subjects: 160
Study: 21975419

Group type: EXPERIMENTAL
Intervention: Elliptical exercise intervention, 15 sessions of supervised exercise
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Elliptical exercise intervention
Number of subjects: 24
Study: 20818888

Group type: EXPERIMENTAL
Intervention: Icatibant (30 mg subcutaneously)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130

Group type: COMPARATOR
Intervention: Tranexamic acid (3 g daily for 2 days)
Number of subjects: 130
Study: 17472802

Group type: EXPERIMENTAL
Intervention: New treatment options for ARMD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endpoints of clinical studies
Number of subjects: 0
Study: 16120062

Group type: EXPERIMENTAL
Intervention: 0.375 mg triazolam
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 12392589

Group type: EXPERIMENTAL
Intervention: Saliva nicotine concentration
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Plasma nicotine concentration
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saliva and plasma nicotine concentrations
Number of subjects: 13
Study: 9987093

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (1 microgram/kg/min for over 15 min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7572826

Group type: EXPERIMENTAL
Intervention: JOBS II intervention for unemployed workers
Number of subjects: 1801